Wells Fargo & Company Aditxt, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.13 - $0.46 $3 - $12	28 Added 11.62%	269 $0
Q1 2022 May 16, 2022	BUY	$0.34 - $0.58 $31 - $53	92 Added 61.74%	241 $0
Q4 2021 Feb 14, 2022	BUY	$0.54 - $2.51 $41 - $190	76 Added 104.11%	149 $0
Q3 2021 Nov 15, 2021	BUY	$1.54 - $3.04 $13 - $27	9 Added 14.06%	73 $0
Q2 2021 Aug 16, 2021	SELL	$2.2 - $3.2 $2,635 - $3,833	-1,198 Reduced 94.93%	64 $0
Q1 2021 May 13, 2021	BUY	$2.08 - $5.26 $2,512 - $6,354	1,208 Added 2237.04%	1,262 $3,000
Q4 2020 Feb 09, 2021	BUY	$1.89 - $2.48 $66 - $86	35 Added 184.21%	54 $0
Q3 2020 Nov 05, 2020	BUY	$1.7 - $7.6 $32 - $144	19 New	19 $0

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $541K
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.